New pill targets hormone disorder from adrenal tumors
NCT ID NCT05436639
First seen Feb 15, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This study tested a daily pill called SPI-62 in 30 adults with high cortisol levels caused by a non-cancerous adrenal tumor. The goal was to see if the drug could safely lower blood sugar and control the hormone imbalance. Participants took 2 mg of SPI-62 each day for up to 12 weeks, and researchers measured changes in blood sugar levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTONOMOUS CORTISOL SECRETION (ACS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
C.M.D.T.A. Neomed
Brasov, 500283, Romania
-
Institutul National de Endocrinologie
Bucharest, 11863, Romania
-
King's College Hospital
London, SW9 8RR, United Kingdom
-
Mayo Clinic Cancer Center (MCCC) - Rochester
Rochester, Minnesota, 55905, United States
-
Ohio State McCampbell Outpatient Care
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.